Skip to main content
PLOS One logoLink to PLOS One
. 2023 Jul 14;18(7):e0287723. doi: 10.1371/journal.pone.0287723

Malaria infection and its association with socio-demographics, long lasting insecticide nets usage and hematological parameters among adolescent patients in rural Southwestern Nigeria

Azeez Oyemomi IBRAHIM 1,*, Tosin Anthony Agbesanwa 2, Shuaib Kayode AREMU 3, Ibrahim Sebutu BELLO 4,5, Olayide Toyin ELEGBEDE 1, Olusegun Emmanuel GABRIEL-ALAYODE 1, Oluwaserimi Adewumi AJETUNMOBI 1, Kayode Rasaq ADEWOYE 6, Temitope Moronkeji OLANREWAJU 7, Ebenezer Kayode ARIYIBI 7, Adetunji OMONIJO 7, Taofeek Adedayo SANNI 6, Ayodele Kamal ALABI 8, Kolawole OLUSUYI 1
Editor: Segun Isaac OYEDEJI9
PMCID: PMC10348556  PMID: 37450497

Abstract

Background

There is increasing evidence suggesting that adolescents are contributing to the populations at risk of malaria. This study determined the prevalence of malaria infection among the adolescents and examined the associated determinants considering socio-demographic, Long Lasting Insecticide Nets (LLINs) usage, and hematological factors in rural Southwestern Nigeria.

Methods

A hospital-based cross-sectional study was conducted between July 2021 and September 2022 among 180 adolescents who were recruited at a tertiary health facility in rural Southwestern Nigeria. Interviewer administered questionnaire sought information on their socio-demographics and usage of LLINs. Venous blood samples were collected and processed for malaria parasite detection, ABO blood grouping, hemoglobin genotype, and packed cell volume. Data were analyzed using SPSS version 20. A p-value <0.05 was considered statistically significant.

Results

The prevalence of malaria infection was 71.1% (95% CI: 68.2%-73.8%). Lack of formal education (AOR = 2.094; 95% CI: 1.288–3.403), being a rural residence (AOR = 4.821; 95% CI: 2.805–8.287), not using LLINs (AOR = 1.950; 95% CI: 1.525–2.505), genotype AA (AOR = 3.420; 95% CI: 1.003–11.657), genotype AS (AOR = 3.574; 95%CI: 1.040–12.277), rhesus positive (AOR = 1.815; 95% CI:1.121–2.939), and severe anemia (AOR = 1.533; 95% CI: 1.273–1.846) were significantly associated with malaria infection.

Conclusion

The study revealed the prevalence of malaria infection among the adolescents in rural Southwestern Nigeria. There may be need to pay greater attention to adolescent populations for malaria intervention and control programs.

Introduction

Malaria continues to be a significant global health challenge and a major public health issue in several countries, including Nigeria [1]. The disease is transmitted in humans from one person to another through the bites of infected female mosquitoes of the anopheles [2, 3]. There are five species of parasites belonging to the genus Plasmodium, that transmit malaria, of which P. falciparum is the most prevalent [2, 3]. Globally, there were 247 million cases of malaria and 619,000 deaths in 2021 [4]. However, approximately 80% of all deaths due to malaria were concentrated in just 15 countries mainly in the Africa region [2]. Despite frantic efforts and interventions targeted at its elimination, 48% of the world population remains exposed to the risk of malaria, a figure substantially higher than the 40% widely cited [4]. Malaria accounts for the highest number of hospitalizations and outpatient visits in Africa [5, 6].

The prevalence of malaria infection among the adolescent patients varies from place to place, even within the same country, and may be due to differences in socio-demographic, environmental and climatic factors [7, 8]. In Nigeria, malaria prevalence of 66.7% [9], 64.0% [10], and 58.0% [11] have been reported by previous studies. Socio-demographic factors such as age, gender, education, occupation and income, which may directly affect human exposure and treatment, and climatic factors such as temperature, humidity, and rainfall which may support rapid growth and development of mosquito vectors have been well reported in urban and peri-urban centers [8, 11]. In Africa, malaria transmission is comparatively higher among the rural settings than the urban areas, and may be due to the higher vector density, poor housing status, and poor drainage systems in rural settings [8, 12].

Hematological profile may contribute to the clinical presentation of malaria, but not transmission of malaria infection [7, 13]. These changes may be related to the individual’s packed cell volume, ABO blood grouping, and hemoglobin electrophoresis pattern [7, 13]. Anemia has been known to be the usual sign of the parasitic infection in endemic malaria areas with P. falciparum being an important contributor to anemia in children [7, 14]. Anemia is a condition characterized by a decrease in the number of red blood cells (RBCs) or a lower than normal amount of hemoglobin for a person’s age and gender. The World Health Organization defines anemia as a hemoglobin level of less than 12g/dL in non-pregnant women aged 15 and older, and less than 13g/dL in men aged 15 and older [15]. These values reflect a deficiency in the number of red blood cells or inadequate hemoglobin levels, both of which are defining features of anemia. Resistance to malaria is characterized by the development of an immune response acquired by the host and also depends on innate features as protective factor against infections. Such innate features include ABO blood grouping, sickle cell trait (HbAS), and sickle cell disease (HbSS) [16]. The role of ABO blood group and the genetic make-up in adolescents susceptibility to malaria have not been fully studied [7, 13, 14]. Though, several studies on malaria infection with ABO blood grouping and hemoglobin genotype have been reported in urban areas of Nigeria, however, many of such studies involved pregnant women and the under five children which are considered the most vulnerable groups [7, 8, 13]. There is a growing body of evidence suggesting that school-aged children and adolescents are also at risk of malaria [13, 14]. Moreover, due to a decline in transmission and exposure in some areas, the peak age of clinical attacks of malaria is shifting from very young to older children and adolescents [13, 15].

In order to adapt malaria control strategies to changes in transmission patterns in rural settings, there is urgent need for data on prevalence of P. falciparum infection and its associated factors among adolescent age groups in rural Nigeria. Identifying key risk factors for malaria infection are vital for decision makers in malaria prevention and control programs. Therefore, this study determined the prevalence of malaria infection among adolescent age groups and examined the associated determinants considering socio-demographic, Long Lasting Insecticide Nets Usage (LLINs) and hematological factors in rural community of Ekiti State, Southwestern Nigeria.

Materials and methods

Study area/design/period

A hospital-based cross-sectional study was carried out between July 2021 and September 2022 at the Federal Teaching Hospital, Ido-Ekiti (FETHI), Southwestern Nigeria. Ido-Ekiti is a rural community in Ekiti State and has a total land area of 332km2 and a total population of 159,114 inhabitants, according to the most recent population census conducted in 2006 [17]. The annual population growth rate is 3.2%, with the population in 2019 estimated to be 225,305 inhabitants [17]. The study area, Ido-Ekiti, is situated in a tropical rainforest characterized by climatic and environmental conditions that promote the growth and transmission of malaria [18, 19]. Malaria transmission occurs throughout the year, with the primary causative agent being P. falciparum [18]. The people are mainly farmers and traders in the informal sector with a relatively small portion of the working population and retirees in the formal sector [17]. In the study area, malaria transmission is perennial during the raining season (April–October) with P. falciparum being the major causative agent [19]. The health facility offers secondary and tertiary care to the people of its catchment area and its neighborhood states. The hospital has three outreach branches which were accredited for postgraduate residency training in family medicine, pediatrics and other core clinical specialties. Recruitment procedure and collection of data were done by the trained resident doctors and medical officers at the family medicine, Igogo and Ado clinic, and adult emergency unit of FETHI.

Study population

This comprised all adolescent populations who presented to the family medicine, Igogo and Ado clinics, and adult emergency unit of the hospital.

Inclusion criteria

Adolescent patients aged 10–19 years bracket who presented with febrile illness (with an axillary temperature ≥37.5°C) and included those who consented (aged 18 years and above) and those who assented by adults (below 18 years of age).

Exclusion criteria

Patients who were too ill that required immediate attention or those with mental illness. Also, those on treatment for malaria or have just completed anti malaria within two weeks prior to the conduct of this study.

Sample size determination

This was determined using Araoye formular [20].

n = Z2 P(1-P) and nf=n1+nN with a prevalence (P) of 84.2% [21] in a previous study on prevalence of malaria infection amongst students of a southwest Nigerian federal university at 5% margin of errors and 95% confidence interval. where n = minimum sample size when the population (N) of the participants in the study area was greater than 10,000 over a period of one year and nf is the minimum sample size when the population (N) of the participants was less than 10,000. From the year 2019 medical records of adolescent patients with malaria, N was 780 in 2020, Z = 1.96%.

n=Z2P(1P)/d2=(1.96)2×0.842(1.0000.842)/0.0025=204.
Sincenf=n1+nN=204/1+(204/780)
=204/1.416806=161.

An attrition of 10% was added to cater for drop-out or loss of data and the minimum sample size was increased to 180 which was used for this study.

Sampling technique

Systematic random sampling technique was used in this study. The sampling frame is the total number of febrile adolescent individuals expected during the study period. Data from the records department for 2019 gave a sampling frame of 540 over a period of 14 (54 weeks) months. Dividing the sampling frame by the sample size (180) gave a sampling interval of three (3). On each screening day, the third registered respondent was selected by systematic random sampling technique, and subsequently every third respondent were selected and process was repeated on each clinic day throughout the study period until the sample size of 180 was attained. Recruited individuals had their record cards tagged to prevent re-enrolment. The recruitment of the subjects was done by three trained resident doctors who served as research assistants while the researcher did the collection of data.

Ethical clearance, consideration and consent

The study was approved by the Ethics and Research Committee of federal teaching hospital, Ido-Ekiti (ERC/2021/06/23/601A). When seeking consent from the respondents who were 18 year and above or assent from the guidance/parents of the respondent below aged 18 years, the methods and objectives of the study were explained clearly to the respondents individually. For those respondents that could not read or write, the questionnaire was translated from English language to their local language by an independent interpreter who served as their legal guardian while back translation to English language was done to maintain response consistency. The respondents were told that they were free to refuse or disengage participation at any time without losing any benefit of care or favor to those that participated. Thus, written informed consent either by appending signature or thumbprint was obtained from all adult respondents and guardians/parents on behalf of their children before starting the study. Confidentiality and privacy were ensured throughout the study. The study was at no cost to the respondents. The respondents with positive malaria parasite were treated with the standard medication according to the national malaria drug policy. The reporting of this study conforms to the strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement [22].

Data collection instruments and procedure

The two instruments for data collection were the interviewer administered questionnaire and data collection form. The questionnaire sought information about the respondents’ socio-demographic characteristics (such as age, gender, education, occupation, and location), ownership and the usage of Long Lasting Insecticide Nets (LLINs).

Clinical parameters of the respondents

Sample collection

Samples of blood (about 5ml) were obtained intravenously with the assistance of hospital phlebotomist. The blood samples were transferred into an ethylenediaminetetraacetic acid (EDTA) bottle to prevent blood coagulation.

  1. Microscopy for malaria parasite: Two blood films, one thin and one thick were made from the blood samples. The thick and thin smears were prepared on clean, dry microscope glass slides and were allowed to dry. The thin smear was fixed in methanol and both smears were stained with 2% Giemsa BDH Laboratory supplies; Poole BH 15 ITD England [21]. The slides were viewed under a microscope using oil immersion at 100x magnification. Staining of the slides and parasite counting were made independently by two microscopists with discrepancies resolved by a senior microscopist who ensured quality control. The films were viewed for the presence of parasite. A negative result would mean absence of parasites at 200 high power fields. Parasite density was quantified against 200 leucocytes on an assumed leucocyte count of 8000 per ul of blood [23]. The degree of parasite density was graded as mild, moderate, and severe when the counts were <1000 parasites/ul of blood, 1000-9999/ul of blood, and ≥ 10,000/ul of blood, respectively, following the method described elsewhere [9].

    Parasites/ul of blood = No. of asexual stages × 8000 leukocytes/200 leukocytes

  2. Determination of genotype: The genotype of each respondent was determined as described by Ochei and Kolhatkar [24]. About 1ml of blood samples were withdrawn from the EDTA bottle and centrifuged at 2500 rpm for 5 minutes. The supernatant was then discarded and packed cells were washed with normal saline for three times. The red cells were lysed by adding an equal volume of distilled water, one quarter (1/4) of toluene followed by a drop of 3% KCN after the final wash. It was then mixed properly. Haemoglobin genotype separation was carried out using electrophoresis method as described by Cheesbrough [25].

  3. Determination of ABO blood group. A drop of blood taking from the blood samples was placed on a clean slide in four concentric zones. Then, a drop of each of the anti-sera, anti-A, anti-B, and anti-D was added and mixed with each of the blood samples with the aid of a sterile stick. Blood groups were determined on the basis of agglutination method [26].

  4. Determination of Packed cell volume (PCV): A micro-haematocrit tube was filled with blood and centrifuge in a micro-haematocrit rotor at 10,000 rpm for 5 minutes. PCV was read using the micro-haematocrit reader, and recorded as, no anemia (PCV≥30%), mild anemia (25–29%), moderate anemia (20–24%), and severe anemia (<20%) [25].

Quality control

To ensure that the authorized standard operating procedure was followed for all the investigations, a senior microscopist was recruited to examine the slides for quality control. Our methodology may be reproduced by fellow researchers if they so desire.

Treatment of the respondents

The results of the investigations were transmitted to the managing physicians through the patients. Respondents with malaria parasitaemia were treated with the standard medication in accordance with the national malaria drug policy.

Data entry and analysis

Data collected were checked, cleaned and entered into EPI Info Version 7.0 and were exported to IBM SPSS for window version 21.0 (IBM Corp., Armonk, NY, USA), respectively for analysis. Quantitative data were expressed as mean ± standard deviation. Frequencies were used to determine the prevalence of malaria infection in the respondents. Binary logistic regression was employed to assess the determinants of Plasmodium infection. Variables significant at P-value < 0.05 in the univariate logistic regression were selected for multivariate logistic regression analysis model. Odds ratios with 95% confidence intervals were calculated. For each category of the independent variable, the one with least Olds ratio was categorized as constant reference “Ref” and P-value < 0.05 was considered to be statistically significant.

Results

A total of 180 respondents were screened during the study period. The distribution according to socio-demographic characteristics showed that the majority of the respondents 97 /180 (53.9%) were young children within the ages of 10–14 years. The mean age of the respondents was 14.5±2.7 years (range: 10–19 years). There were more males 94/180 (52.7%) than females 86/180 (47.8%). Many of the respondents were unemployed 125 (69.4%) and majority were secondary school students 101 (56.1%), and were rural dwellers 139 (77.2%), (Table 1).

Table 1. Socio-demographic characteristics of respondents.

Variable Frequency Percentage
(N = 180) (%)
Age (in years)
10–14 97 53.9
15–19 83 46.1
Mean age ± SD 14.5 ± 2.7
Range 10–19
Sex
Male 94 52.2
Female 86 47.8
Occupation
Farmer 16 8.9
Trader 18 10.0
Student 125 69.4
Artisan 21 11.7
Education
None 8 4.4
Primary 47 26.1
Secondary 101 56.1
Tertiary 24 13.4
Domicile
Rural 139 77.2
Urban 41 22.8

The majority of the respondents tested positive to only Plasmodium falciparum 128/180; 71.1% (95% CI: 68.2%-73.8%) which was identified from thin blood smear. Of the 128 diagnosed with Plasmodium falciparum, 72/128 (40.0%), 40/128(22.0%), and 16/128 (9.0%) had mild, moderate, and severe parasitaemia from thick blood smear respectively (Table 2).

Table 2. Prevalence of malaria parasitaemia among the respondents.

Variables Frequency Percentage(%)
Malaria parasitaemia by density (N = 128)
Mild parasitaemia (<1000 parasites/ul of blood) 72 56.3
Moderate parasitaemia (1000–9999 parasites/ul of blood) 40 31.2
Severe parasitaemia (≥10,000 parasites/ul of blood) 16 12.5
Malaria parasitaemia from thin blood smear
Positive 128 71.1
Negative 52 28.9
95% Confidence Interval (68.2%– 73.8%)

After adjusting for possible confounders; the odds of being infected with P. falciparum infection was 2.094 times (95% CI:1.288–3.403) higher among the respondents who had no formal education, 4.821 times (95% CI: 2.805–8.287) higher among the respondents who were rural dwellers, 1.950 times (95% CI: 1.525–2.505) higher among the respondents who were not using LLINs, 3.420 times (95% CI: 1.003–11.657) higher among the respondents who were hemoglobin genotype A, 3.574 times (95% CI: 1.040–12.277) higher among the respondents who were genotype AS, 1.815 times (95% CI: 1.121–2.939) higher among the respondents who were rhesus positive, and 1.533 times (95% CI: 1.273–1.846) higher among the respondents who had severe anemia, (Table 3).

Table 3. Crude and adjusted odd ratios for the factors significantly associated with malaria parasitaemia (N = 180).

Variable +ve % -ve % COR (95% CI) p-value AOR (95% CI) p-value
Age (in years)
10–14 70 (54.7) 27(51.9) 1.117 (0.586–2.132) 0.736 1.033 (0.856–1.246) 0.863
15–19 58(45.3) 25(48.1) 1.000 1.000
Sex
Male 70(54.7) 24(46.2) 1.408 (0.737–2.689) 0.299 1.104 (0.914–1.333) 0.326
Female 58(45.3) 28(53.8) 1.000 1.000
Occupation
Farmers 12(9.4) 4(7.7) 6.000 (1.407–25.590) 0.012 2.250 (0.923–4.387) 0.234
Traders 11(8.6) 7(13.5) 3.143 (0.846–11.671) 0.083 1.833 (0.903–3.723) 0.158
Students 98(76.5) 27(51.9) 7.259 (2.664–19.779) <0.001 2.352 (0.863–4.337) 0.234
Artisan (ref) 7(5.5) 14(26.9) 1.000 1.000
Education
None 6(4.7) 2(3.9) 4.200 (0.698–25.265) 0.102 2.094 (1.288–3.403) 0.013
Primary 71(55.5) 30(57.7) 9.567 (2.940–31.135) <0.001 1.800 (0.969–3.345) 0.108
Secondary 41(32.0) 6(11.5) 3.133 (1.325–8.288) 0.008 1.687 (0.876–2.754) 0.127
Tertiary (ref) 10(7.8) 14(26.9) 1.000 1.000
Domicile
Rural 117(91.4) 22(42.3) 25 (11.363–55.621) <0.001 4.821 (2.805–8.287) 0.015
Urban (ref) 11(8.6) 30(57.7) 1.000 1.000
LLITNs
Yes (ref) 36(28.1) 42(80.8) 1.000 1.000
No 92(71.9) 10(19.2) 10.733 (4.871–23.650) <0.001 1.950 (1.525–2.505) 0.003
Genotype
AA 95(74.2) 30(57.6) 11.083 (2.184–56.242) 0.001 3.420 (1.003–11.657) 0.002
AS 27(21.0) 7(13.4) 13.500 (2.282–79.880) 0.001 3.574 (1.040–12.277) 0.004
AC 2(1.6) 2(3.8) 1.167 (0.124–10.991) 0.893 1.125 (0.203–6.239) 1.000
SC 2(1.6) 2(3.8) 3.500 (0.284–43.163) 0.317 2.250 (0.470–10.779) 0.726
SS (ref) 2(1.6) 7(13.4) 1.000 1.000
Blood group
O 63(49.3) 19(36.5) 9.118 (2.62–31.958) <0.001 2.881 (0.734–6.725) 0.098
A 33(25.8) 9(17.3) 4.776 (1.333–17.111) 0.012 2.380 (0.832–5.648) 0.177
B 28(21.9) 13(25.0) 5.923 (1.582–22.172) 0.005 2.561 (0.927–6.081) 0.141
AB (ref) 4(3.1) 11(21.2) 1.000 1.000
Rhesus factor
Rh D Positive 118(92.2) 38(73.1) 4.347 (1.785–10.587) <0.001 1.815 (1.121–2.939) 0.001
Rh D Negative (ref) 10(7.8) 14(26.9) 1.000 1.000
PCV
≥ 30% (ref) 63(49.2) 41(78.9) 1.000 1.000
25–29% 22(17.2) 5(9.6) 2.864 (1.004–8.164) 0.043 1.345 (0.657–1.706) 0.453
20–24% 17(13.3) 4(7.7) 2.766 (0.869–8.806) 0.076 1.336 (0.453–2.748) 0.127
< 20% 26(20.3) 2(3.8) 8.460 (1.905–37.579) 0.001 1.533 (1.273–1.846) 0.001

ref–reference category COR–Crude Odd Ratio AOR–Adjusted Odd Ratio +ve–positive parasitaemia, -ve—negative parasitaemia

Discussion

The study identified the prevalence of malaria infection and examined the socio-demographics, LLINs Usage and hematological parameters-based factors that determine the likelihood of malaria infection among adolescents aged 10–19 years in rural Southwestern Nigeria. The prevalence of malaria infection (71.1%) found in this study was comparable to a cross sectional study conducted among school aged participants in Abia Southeastern Nigeria which reported prevalence of 68.1% [27]. This may be due to the similarity in the study population, climatic factors, and the use of bed nets. In contrast, the prevalence of malaria in this study was high than 12.9% reported in a cross sectional study conducted in Kano Northwestern Nigeria [28]. It was also higher than 35.7% reported in another study conducted in Kaduna North-central Nigeria [29], and 36.6% reported in Plateaus North central Nigeria [27]. This could be due to the differences in the prevailing climatic conditions and environmental factors of our study area compared to other studies that were conducted in Northern Nigeria. Previous study across the regions of Nigeria had reported a higher prevalence of malaria infection in the Southwestern Nigeria compared to the Northern Nigeria [27, 30]. Thus, differences in settings, season variations, and environment factors conducive for malaria vectors to thrive might be responsible for this finding [27, 30]. Furthermore, the prevalence of malaria in this study was lower than the results of a cross sectional study conducted among students of a southwest Nigerian federal university (80.6%) [31], and in Southern Tanzania (78.0%) [32]. The low prevalence in this study compared to the other previous malaria study in Akwa, Southeastern Nigeria might be attributed to the usage of insecticide treated nets as well as the setting. However, it is noteworthy to state that malaria prevalence recorded in this study is of public health importance and could be attributed to several factors in the study area such as climatic, vegetation and environmental factors and the increase chances of participants contact with malaria [30].

Furthermore, our finding revealed that P. falciparum was the only Plasmodium species encountered in this study. This is comparable to cross sectional study conducted in other malaria endemic setting [14]. This finding was not surprised given the fact that P. falciparum is the dominant Plasmodium species in Southwestern Nigeria [30, 33], Africa [34], and 99.7% estimated malaria cases of P. falciparum have been documented from WHO African regions [1]. It is responsible for the reported high morbidity and mortality among children, especially in sub-Sahara Africa countries. Using multivariate regression for factors that were significantly associated with malaria infection in this study, respondents who had no formal education were 3.403 times more likely to increase the odds of malaria infection as compared to those who had formal education. This was similar to cross sectional studies conducted in Ibadan Southwestern Nigeria [11], Kano Northwestern Nigeria [9], and Kenya [35], which showed that level of education significantly influences the knowledge, attitude, and practice of people in various malaria interventions, treatment, and control [9, 11, 33, 35].

Similarly, the respondents who were rural dwellers were 4.821 times more likely to increase the odds of malaria infection. This was in agreement with studies conducted in Ibadan Southwestern Nigeria [11] and Kenya [36]. However, other cross sectional studies conducted in Kano Northwestern Nigeria [28], and other Africa country [37], have reported a high prevalence of malaria infection among the urban residents. The increased odds of malaria infection among the rural dwellers in this study may be due to their low level of education, environmental factors, and improper use of LLINs which have been identified as contributory factors for malaria infections in this study. Other studies have attributed the increased odds of malaria infection in rural areas to lack of social mobilization concerning malaria prevention [35, 36].

In this study, less than half of the respondents (43.3%) reported usage of LLINs, despite that the majority are in possession of LLINs. This was in agreement with cross sectional studies conducted in various parts of Africa, where LLIN has been shown to be at its lowest among school children [7, 11, 27]. Awareness campaign on malaria prevention with sustained and effective communication strategies geared towards transmission of ownership into usage is recommended. The use of LLINs in this study was found to be significantly associated with reduction of malaria infection as the results showed that respondents who denied usage of LLINs were 1.950 times more likely to have malaria infection as compared to the respondents who did. This finding was consistent with the reports of studies conducted in central Nigeria [7], Southwestern Nigeria [11], and western Kenya [38]. Appropriate utilization of LLINs is one of the major cost effective interventions adopted for the prevention of malaria transmission in endemic settings [30, 33]. This finding further reinforces the usefulness of LLINs and calls for its continuous awareness campaign to improve its usage in rural settings [30].

The study showed that respondents who were of hemoglobin genotype AA were associated with increased odds of malaria infections. This findings was consistent with findings in other studies reported in literatures [36, 37, 39, 40]. From results obtained in this study and reports of previous and similar studies, it is also clear that malaria infection rates were lowest for HbSS [38, 41]. The high prevalence of malaria in the AA hemoglobin genotype variant compared to SS may be due to high rate of oxygen consumption and a large amount of hemoglobin ingested in the peripheral blood during the stage of replication [3941]. Thus, malaria parasite found hemoglobin AA more conducive to strive than hemoglobin genotype SS because the red cells are conducive for the growth and development of the parasites [42].

This study also showed that respondents who were rhesus positive were 1.815 times more likely to increase the odds of malaria infection as compared to respondents who were rhesus negative. The pathophysiology of rhesus blood group in the protective or risk factor for malaria infection remains unclear. However, it may be due to alteration of adhesive properties of the parasites to the red blood cells (RBCs) membrane and subsequent sequestration of RBCs in less desirable locations for Plasmodium infection [43]. There are very few studies that looked at the association between malaria and rhesus blood group. The finding in the current study was comparable to the study by Mukhtar et al, which found a positive association between malaria parasites and rhesus positive [44]. In contrast to the current study, Bamou and Sevidzem found that rhesus factor has no impact on malaria infection [45]. Further studies using prospective designs and a definitive method of Plasmodium identification are needed to identify the association between P.falciparum and rhesus individuals.

In this study, anemia was found to be significantly associated with malaria infection. This finding was consistent with the reports of previous study conducted among school aged populations in Abia State [27]. However, study by Umaru and colleague in Kaduna State Nigeria found no significant association between anemia and malaria infection [29]. The mechanism through which malaria infection causes anemia in rural dwellers is multi-factorials. It is possible that the respondents may have been anemic initially as a result of micronutrients deficiency, and further attack of malaria may worsen the level of anemia in them [30]. The results of the current study demonstrate that adolescents with a reduction in packed cell volume are at a higher risk of malaria infection. Specifically, the study found an increased prevalence of malaria infection among this group, highlighting the association between low packed cell volume and malaria risk [30, 39]. Physiologically, school aged children are susceptible to malaria infection due to their loss of acquired immunity, and thus increased likelihood of being anemic [27, 34].

Limitations

This study was based on cross sectional design and thus, had limited opportunities to measure any causal association between malaria infection and other factors. The lack of children less than 10 years old was also a possible limitation for having a real burden of malaria in these older children and adolescents. Hemoglobin level was only assessed at base line; measurement of hemoglobin level for each suspected case could have provided a better assessment of the association between anemia and malaria in the study area [38]. Despite these limitations, the study provided a vital information regarding the burden of, and associated risk factors for malaria infection among the adolescents, which could be needed to recommend appropriate interventions for malaria prevention and control in rural Southwestern Nigeria [30, 33].

Conclusion

In this study, the prevalence of malaria infection was 71.0%. The respondents with lack of formal education, rural residence, not using LLINs, blood hemoglobin genotype AA and AS, rhesus positive individuals, and having severe anaemia were significantly associated with the risk of malaria infection. The study demonstrated the need to pay attention to adolescent populations in rural settings for malaria interventions and control programs. The results may assist the stakeholders in recommending appropriate interventions for malaria prevention and control in rural Southwestern Nigeria [28].

Supporting information

S1 File

(DOCX)

S1 Data

(XLSX)

Acknowledgments

The authors would like to appreciate the participants, and also nurses, resident doctors and medical officers at the family medicine, outreach centers, and adult emergency medicine departments and the management of FETHI where the study was conducted.

Data Availability

All relevant data are within the paper and its Supporting Information files.

Funding Statement

The authors received no specific funding for this work.

References

  • 1.World Health Organisation. World Malaria Report 2018 [Internet]. 2018 [Last accessed 2021 Jun 16];Available from: https://apps.who.int/iris/bitstream/handle/10665/275867/9789241565653-eng.pdf
  • 2.World Health Organization. World Malaria Report: 20 years of global progress and challenges [Internet]. 2020 [Last accessed 2023 Feb 18];Available from: https://apps.who.int/iris/handle/10665/337660
  • 3.Centres for Disease Control and Prevention. CDC—Malaria—About Malaria—FAQs [Internet]. 2022 [Last accessed 2023 Feb 18];Available from: https://www.cdc.gov/malaria/about/faqs.html
  • 4.World Health Organisation. World malaria report 2022: Tracking progress and gaps in the global response to malaria [Internet]. 2022 [Last accessed 2023 Feb 16];Available from: https://www.who.int/teams/global-malaria-programme/reports/world-malaria-report-2022
  • 5.Omoya FO, Ajayi KO. Prevalence of Malaria among Febrile Patients attending Government Hospitals in Ondo State, South-West Nigeria. Am J Epidemiol Public Health 2020;4(4):017–024. [Google Scholar]
  • 6.World Health Organisation. Malaria [Internet]. 2023 [Last accessed 2023 May 12];Available from: https://www.who.int/news-room/fact-sheets/detail/malaria
  • 7.Yohanna J, Oti V, Amuta E, Philip A, Anizoba L. Plasmodium falciparum Infection among Febrile Patients Attending a Tertiary Healthcare Facility in Central Nigeria: Prevalence, Hematologic and Sociodemographic Factors. Int J Trop Dis 2019;2(2). [Google Scholar]
  • 8.Ngum NH, Fakeh NB, Lem AE, Mahamat O. Prevalence of malaria and associated clinical manifestations and myeloperoxidase amongst populations living in different altitudes of Mezam division, North West Region, Cameroon. Malar J 2023;22(1):20. doi: 10.1186/s12936-022-04438-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Dawaki S, Al-Mekhlafi HM, Ithoi I, Ibrahim J, Atroosh WM, Abdulsalam AM, et al. Is Nigeria winning the battle against malaria? Prevalence, risk factors and KAP assessment among Hausa communities in Kano State. Malar J 2016;15(1):351. doi: 10.1186/s12936-016-1394-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Nmadu PM, Peter E, Alexander P, Koggie AZ, Maikenti JI. The Prevalence of Malaria in Children between the Ages 2–15 Visiting Gwarinpa General Hospital Life-Camp, Abuja, Nigeria. J Heal Sci 2015;5(3):47–51. [Google Scholar]
  • 11.Awosolu OB, Yahaya ZS, Farah Haziqah MT, Simon-Oke IA, Fakunle C. A cross-sectional study of the prevalence, density, and risk factors associated with malaria transmission in urban communities of Ibadan, Southwestern Nigeria. Heliyon 2021;7(1):e05975. doi: 10.1016/j.heliyon.2021.e05975 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Oladeinde B, Omoregie R, Olley M, Anunibe J, Onifade A, Oladeinde O. Malaria and Anemia among Children in a Low Resource Setting In Nigeria. Iran J Parasitol 2012;7(3):31–37. [PMC free article] [PubMed] [Google Scholar]
  • 13.National Malaria Elimination Programme: The Federal Republic of Nigeria. National Malaria Strategic Plan 2014–2020 [Internet]. 2014 [Last accessed 2021 May 21];Available from: https://www.health.gov.ng/doc/NMEP-Strategic-Plan.pdf
  • 14.Osaro E, Jamilu MH, Ahmed H, Acu E. Effect of plasmodium Parasitaemia on some haematological parameters in children living in Sokoto, North Western, Nigeria. Int J Clin Med Res 2014;1(2):57–64. [Google Scholar]
  • 15.World Health Organisation. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity [Internet]. Vitam. Miner. Nutr. Inf. Syst.2011 [Last accessed 2023 May 12];Available from: https://apps.who.int/iris/bitstream/handle/10665/85839/WHO_NMH_NHD_MNM_11.1_eng.pdf
  • 16.Amala SE, Nwibani CP. Malaria in pregnancy and its association with ABO blood group and haemoglobin genotype. Int J Dev Res 2015;5(8):5317–5320. [Google Scholar]
  • 17.National Population Commission. Distribution by sex, State, LGA and Senatorial district (Priority table volume III): 2006 population and housing census. Abuja, Nigeria: 2010.
  • 18.Centres for Disease Control and Prevention. Where Malaria Occurs [Internet]. 2020 [Last accessed 2023 May 12];Available from: https://www.cdc.gov/malaria/about/distribution.html
  • 19.Ekiti State Government. About Ekiti [Internet]. 2023 [Last accessed 2023 May 12];Available from: https://www.ekitistate.gov.ng/about-ekiti/
  • 20.Araoye MO. Subject selection. In: Research methodology with statistics for health and social sciences. Ilorin: Nathadex; 2004. page 117–118. [Google Scholar]
  • 21.Awosolu O, Adesina F, Afolabi O, Ogunsanya D. Malaria parasite distribution and knowledge among students of Federal University Of Technology, Akure, Nigeria. Anim Res Int 2021;17(3). [Google Scholar]
  • 22.Elm E von, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ 2007;335(7624):806–808. doi: 10.1136/bmj.39335.541782.AD [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Monif GRG, Sebastian F, Baker DA. Infectious Diseases in Obstetrics and Gynecology. CRC Press; 2013. [Google Scholar]
  • 24.Ochei J, Kolhalkar A. Miscellaneous investigation in Haematology, Medical Laboratory Science, theory and practical data. India: McGraw-Hill Publishing Company Limited; 2008. [Google Scholar]
  • 25.Cheesbrough M. District Laboratory Practice in Tropical Countries. Low price. Publisher Cambridge University Press; 2010. [Google Scholar]
  • 26.Chapter Dean L. 5, The ABO blood group. In: Blood Groups and Red Cell Antigens. Bethesda (MD): National Center for Biotechnology Information (US); 2005. [Google Scholar]
  • 27.Noland GS, Graves PM, Sallau A, Eigege A, Emukah E, Patterson AE, et al. Malaria prevalence, anemia and baseline intervention coverage prior to mass net distributions in Abia and Plateau States, Nigeria. BMC Infect Dis 2014;14(1):168. doi: 10.1186/1471-2334-14-168 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Oladele OV, Onuoha SC, Hamafyelto HS, Omisope O, Fauziyya A, Akindigh M, et al. Prevalence of malaria infection among patients attending Murtala Muhammed specialist hospital Kano, Nigeria. African J Clin Exp Microbiol 2019;19(3):214–220. [Google Scholar]
  • 29.Umaru ML, Uyaiabasi GN. Prevalence of Malaria in Patients Attending the General Hospital Makarfi, Makarfi Kaduna–State, North-Western Nigeria. Am J Infect Dis Microbiol 2015;3(1):1–5. [Google Scholar]
  • 30.Ibrahim AO, Bello IS, Shabi OM, Omonijo AO, Ayodapo A, Afolabi BA. Malaria infection and its association with socio-demographics, preventive measures, and co-morbid ailments among adult febrile patients in rural Southwestern Nigeria: A cross-sectional study. SAGE Open Med 2022;10:205031212211178. doi: 10.1177/20503121221117853 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Erinle BA, Bada EO. Prevalence of malaria infection amongst students of a southwest Nigerian federal university. GSC Adv Res Rev 2023;15(1):110–114. [Google Scholar]
  • 32.Harchut K, Standley C, Dobson A, Klaassen B, Rambaud-Althaus C, Althaus F, et al. Over-diagnosis of malaria by microscopy in the Kilombero Valley, Southern Tanzania: an evaluation of the utility and cost-effectiveness of rapid diagnostic tests. Malar J 2013;12(1):159. doi: 10.1186/1475-2875-12-159 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Ibrahim AO, Bello IS, Ajetunmobi AO, Ayodapo A, Afolabi BA, Adeniyi MA. Prevalence of asymptomatic malaria infection by microscopy and its determinants among residents of Ido-Ekiti, Southwestern Nigeria. PLoS One 2023;18(2):e0280981. doi: 10.1371/journal.pone.0280981 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Hay SI, Guerra CA, Tatem AJ, Atkinson PM, Snow RW. Urbanization, malaria transmission and disease burden in Africa. Nat Rev Microbiol 2005;3(1):81–90. doi: 10.1038/nrmicro1069 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Imbahale SS, Fillinger U, Githeko A, Mukabana WR, Takken W. An exploratory survey of malaria prevalence and people’s knowledge, attitudes and practices of mosquito larval source management for malaria control in western Kenya. Acta Trop 2010;115(3):248–256. doi: 10.1016/j.actatropica.2010.04.005 [DOI] [PubMed] [Google Scholar]
  • 36.Sultana M, Sheikh N, Mahumud RA, Jahir T, Islam Z, Sarker AR. Prevalence and associated determinants of malaria parasites among Kenyan children. Trop Med Health 2017;45(1):25. doi: 10.1186/s41182-017-0066-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Kuesap J, Na-Bangchang K. The Effect of ABO Blood Groups, Hemoglobinopathy, and Heme Oxygenase-1 Polymorphisms on Malaria Susceptibility and Severity. Korean J Parasitol 2018;56(2):167–173. doi: 10.3347/kjp.2018.56.2.167 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Kepha S, Nikolay B, Nuwaha F, Mwandawiro CS, Nankabirwa J, Ndibazza J, et al. Plasmodium falciparum parasitaemia and clinical malaria among school children living in a high transmission setting in western Kenya. Malar J 2016;15:157. doi: 10.1186/s12936-016-1176-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Njila HL, Idoko JE, Ombugadu A, Zakari H. Hemoglobin genotype variants and Plasmodium falciparum malaria in children receiving postpartum care at Faith Alive Foundation Jos, Plateau, State, Nigeria. Arch Comm Med Public Health. 2022; 8(4):147–151. [Google Scholar]
  • 40.Albiti AH, Nsiah K. Comparative haematological parameters HbAA and HbAS genotype children infected with Plasmodium falciparum malaria in Yemen. Hematology. 2014; 19 (3): 169–174. [DOI] [PubMed] [Google Scholar]
  • 41.Ebadan MI, Obodo BN, Amiegheme FE, Uwaifo F, Omigie BE, Iyevhobu LK., et al. Prevalence and susceptibility of malaria parasites infection in association with blood group and hemoglobin genotype polymorphism in pregnancy. Inter J Comm Res. 2017; 6(2): 2–8. [Google Scholar]
  • 42.Okwa OO. Preliminary investigations on malaria in sickle cell patients among pregnant women and infacts in Lagos, Nigeria. Nig J Parasitol. 2004; 25(1): 81–85 [Google Scholar]
  • 43.Tougan TE. Edula JR, Morita M, Takashima E, Honma H, Tsubol T, et al. The malaria parasite Plasmodium falciparum in red blood cells selectively takes up serum proteins that affect host pathogenicity. Malar J. 2020;19: 155. doi: 10.1186/s12936-020-03229-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Mukhtar IG, Rahmat S, Salisu AI. Relationship between ABO and Rhesus blood group phenotypes and malaria among a population of undergraduate students in Kano, Nigeria. FUDMA J Sci. 2020; 4(1):133–137. [Google Scholar]
  • 45.Bamou R, Sevidzem SL. ABO/Rhesus blood group systems and malaria prevalence among students of the University of Dschang Cameroon. Malar World J. 2016; 7(4): 1–4. [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Segun Isaac OYEDEJI

22 Feb 2023

PONE-D-23-02179MALARIA INFECTION AND ITS ASSOCIATION WITH SOCIO-DEMOGRAPHICS, LONG LASTING INSECTICIDE NETS USAGE AND HEMATOLOGICAL PARAMETERS AMONG ADOLESCENT PATIENTS IN RURAL SOUTHWESTERN NIGERIAPLOS ONE

Dear Dr. Ibrahim,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that the manuscript does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. In addition to the comments raised by the reviewers, the authors will need to re-work the data analysis in Table 3, particularly the percentages and carefully go through the entire manuscript to correct grammatical errors as well as italicize all scientific names.

Please submit your revised manuscript by Apr 08 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Segun Isaac OYEDEJI, Ph.D

Academic Editor

PLOS ONE

Journal requirements:

When submitting your revision, we need you to address these additional requirements.

1.  Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf  and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. In the ethics statement in the Methods, you have specified that verbal consent was obtained. Please provide additional details regarding how this consent was documented and witnessed, and state whether this was approved by the IRB

3. We noticed you have some minor occurrence of overlapping text with the following previous publication(s), which needs to be addressed:

https://pubmed.ncbi.nlm.nih.gov/36051785/

In your revision ensure you cite all your sources (including your own works), and quote or rephrase any duplicated text outside the methods section. Further consideration is dependent on these concerns being addressed.

4. Thank you for stating the following financial disclosure:

“Self funded by authors”

At this time, please address the following queries:

a) Please clarify the sources of funding (financial or material support) for your study. List the grants or organizations that supported your study, including funding received from your institution.

b) State what role the funders took in the study. If the funders had no role in your study, please state: “The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.”

c) If any authors received a salary from any of your funders, please state which authors and which funders.

d) If you did not receive any funding for this study, please state: “The authors received no specific funding for this work.”

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

5. Thank you for stating the following in your Competing Interests section: 

“No competing interest”

Please complete your Competing Interests on the online submission form to state any Competing Interests. If you have no competing interests, please state "The authors have declared that no competing interests exist.", as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now

 This information should be included in your cover letter; we will change the online submission form on your behalf.

6. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Partly

Reviewer #3: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: No

Reviewer #3: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: No

Reviewer #3: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The study of malaria prevalence in adolescent children is a good idea because it was carried out in a relatively neglected population, when it comes to malaria research. Most malaria studies usually involve pregnant women and children below the age of 5 years. Since children and pregnant women are mostly targeted in malaria control measures, there is a risk of malaria epidemiology changing to adolescent and older population. Hence this study is has significant epidemiologic relevance to malaria control. The study was well designed and the sampling method looks very good.

The discussion needs a major review, for instance there was no basis for comparing the prevalence of this study to those whose patient selection was not similar. The result of this study cannot be compared to that of Akure or Lagos where the study populations were apparently health and of different ages.

Outdoor transmissions or development of immunity were not assessed in this study, so they cannot be implied as stated in the discussion. Same with exposure to constant mosquito bites in participants, which was assumed.

Authors should indicate if prevalence of malaria parasitaemia in table 2 was derived from thick film or thin film? Findings from thick film and thin film were not clearly stated in the result section.

Some few grammatical errors:- First line of quality control, “is” should be changed to “was”, Sides not slide, reproduced not reproduce

Regarding the treatment of respondents: Better to clarify that the results were “transmitted to the managing physicians through the patients” than to just write that test results were given to respondents

How was the P. falciparum specie determined in this study?

Limitations- Self report of too many limitations is not good, especially when some of them are avoidable.

Sample size should not be a limitation since it was scientifically derived

Failure to find out the quality of LLITNs is an admission of negligence by the research team, rather than limitation. Better to keep quiet about this.

The conclusion of high malaria prevalence in this study area cannot be safely derived from febrile subjects. This gives a impression that the subjects were apparently healthy.

Overall, this is a good study that is worthy of attention if the results and discussion are well revised

Reviewer #2: The authors provided data on the MALARIA INFECTION AND ITS ASSOCIATION WITH SOCIODEMOGRAPHICS, LONG LASTING INSECTICIDE NETS USAGE AND HEMATOLOGICAL PARAMETERS AMONG ADOLESCENT PATIENTS IN RURAL

SOUTHWESTERN NIGERIA. While I commend the efforts of the authors, I do not feel that the work should be accepted for publication in PlosONE journal following the reasons below:

1. Its difficult for me to trust the microscopy results. Since this is the only method used to confirm Malaria parasite, it would have been nice to follow a standard microscopy procedure. Two microscopists should have done the reading with the third microscopists confirming any discrepancies arising from the reading of the two initial microscopists. Unfortunately, this was not done and that spurs me to recommend rejection.

2. For the calculation of the odd ratio, I feel also that the control group is very small for any meaningful inference.

3. The limitations listed in the manuscripts do not look like an insurmountable challenges but shows that the work was not well planned.

5. I strongly recommend the work to other lower journals where the public could still be reached with the outcome of the research.

6. I am worried that the author did not provide the parasite density results of the microscopy, at least to see to what degree the variables could influence parasite density.

7. The author mentioned that this s a cross-sectional study but none of the results were presented to indicate it so.

8. The -ve and +ve in Table 3 is very confusing. The legend could not provide what they stood for.

Reviewer #3: The methods used and the results obtained have supported the conclusion. All findings are fully described in the manuscript and written in standard English.

Review:

Malaria remains a public health problem. The impacts of different interventions against malaria such as a decline in transmission and exposure in some areas have been recorded, and the peak age of clinical attacks of malaria is shifting from very young to older children and adolescent.

In order to adapt malaria control strategies to changes in transmission patterns, there is urgent need for data on prevalence of P. falciparum infection and its associated factors among adolescent age groups which are crucial for the effective implementation of preventive and health intervention programs. Thus, the authors have raised an important issue on determining the prevalence malaria infection among adolescent age groups and examine the associated determinants considering socio-demographic, Long Lasting Insecticide Nets Usage (LLINs) and hematological factors in rural community of Ekiti State, Southwestern Nigeria.

Minor comments

Introduction

The WHO epidemiological record and others references should be updated (for example, instead of WHO 2015 report use the actual report!)

Materials and methods

The determination of the genotype was not completely described. This should be done.

Results

- Table 2: the parenthesis should be completed;

- Table 3:

� The wrong percentages for Domicile Urban (Ref) and genotype AC should be corrected;

� What are the selection criteria of Ref. for each variable? This should be well explained in the methodology;

� The age and sex should also be considered since the authors have divided the population into two groups (see Table 1)

Limitations:

The lack of children less than 10 years old is also a possible limitation for having a reel burden of malaria in these older children and adolescent.

References

In the section “References”: the ref. 6, 8, 9, 10, 11, 12, 14, 15, 23, 31, 32should be corrected.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Prof Efunshile Akinwale Michael

Reviewer #2: No

Reviewer #3: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: Review 2023.docx

PLoS One. 2023 Jul 14;18(7):e0287723. doi: 10.1371/journal.pone.0287723.r002

Author response to Decision Letter 0


3 Mar 2023

Summary of reviewer’s comments and Authors’ responses. (PONE-D-23-02179)

Reviewer’s comments Authors’ Response

Editor’s comment:

In addition to the comments raised by the reviewers, the authors will need to re-work the data analysis in Table 3, particularly the percentages and carefully go through the entire manuscript to correct grammatical errors as well as italicize all scientific names.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

Journal requirements:

1. Please ensure that your manuscript meets PLOS ONE’s style requirements.

2. In the ethics statement in the Methods, you have specified that verbal consent was obtained. Please provide additional details regarding how this consent was documented and witnessed, and state whether this was approved by the IRB

3.We noticed you have some minor occurrence of overlapping text with the following previous publication(s), which needs to be addressed:

In your revision ensure you cite all your sources (including your own works), and quote or rephrase any duplicated text outside the methods section. Further consideration is dependent on these concerns being addressed.

4. Thank you for stating the following financial disclosure:

“Self funded by authors”

At this time, please address the following queries:

a) Please clarify the sources of funding (financial or material support) for your study. List the grants or

organizations that supported your study, including funding received from your institution

.

b) State what role the funders took in the study. If the funders had no role in your study, please state: “The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.”

c) If any authors received a salary from any of your funders, please state which authors and which funders.

d) If you did not receive any funding for this study, please state: “The authors received no specific funding for this work.”

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

5. Thank you for stating the following in your Competing Interests section:

“No competing interest”

Please complete your Competing Interests on the online submission form to state any Competing Interests. If you have no competing interests, please state "The authors have declared that no competing interests exist.",

This information should be included in your cover letter; we will change the online submission form on your behalf.

6. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide.

5. Review Comments to the Author

Reviewer #1

The discussion needs a major review, for instance there was no basis for comparing the prevalence of this study to those whose patient selection was not similar. The result of this study cannot be compared to that of Akure or Lagos where the study populations were apparently health and of different ages.

-Outdoor transmissions or development of immunity were not assessed in this study, so they cannot be implied as stated in the discussion. Same with exposure to constant mosquito bites in participants, which was assumed.

Authors should indicate if prevalence of malaria parasitaemia in table 2 was derived from thick film or thin film? Findings from thick film and thin film were not clearly stated in the result section.

Some few grammatical errors:- First line of quality control, “is” should be changed to “was”, Sides not slide, reproduced not reproduce

Regarding the treatment of respondents: Better to clarify that the results were “transmitted to the managing physicians through the patients” than to just write that test results were given to respondents

How was the P. falciparum specie determined in this study?

Limitations- Self report of too many limitations is not good, especially when some of them are avoidable. Sample size should not be a limitation since it was scientifically derived

Failure to find out the quality of LLITNs is an admission of negligence by the research team, rather than limitation. Better to keep quiet about this.

The conclusion of high malaria prevalence in this study area cannot be safely derived from febrile subjects. This gives a impression that the subjects were apparently healthy.

Overall, this is a good study that is worthy of attention if the results and discussion are well revised

Reviewer #2:

1. Its difficult for me to trust the microscopy results. Since this is the only method used to confirm Malaria parasite, it would have been nice to follow a standard microscopy procedure. Two microscopists should have done the reading with the third microscopists confirming any discrepancies arising from the reading of the two initial microscopists. Unfortunately, this was not done and that spurs me to recommend rejection.

2. For the calculation of the odd ratio, I feel also that the control group is very small for any meaningful inference.

3. The limitations listed in the manuscripts do not look like an insurmountable challenges but shows that the work was not well planned.

5. I strongly recommend the work to other lower journals where the public could still be reached with the outcome of the research.

6. I am worried that the author did not provide the parasite density results of the microscopy, at least to see to what degree the variables could influence parasite density.

7. The author mentioned that this is a cross-sectional study but none of the results were presented to indicate it so.

8. The -ve and +ve in Table 3 is very confusing. The legend could not provide what they stood for.

Reviewer #3:

Minor comments

Introduction

The WHO epidemiological record and others references should be updated (for example, instead of WHO 2015 report use the actual report!)

Materials and methods

The determination of the genotype was not completely described. This should be done.

Results

- Table 2: the parenthesis should be completed;

ggg

- Table 3:

The wrong percentages for Domicile Urban (Ref) and genotype AC should be corrected;

What are the selection criteria of Ref. for each variable? This should be well explained in the methodology;

The age and sex should also be considered since the authors have divided the population into two groups (see Table 1)

Limitations:

The lack of children less than 10 years old is also a possible limitation for having a reel burden of malaria in these older children and adolescent.

References:

In the section “References”: the ref. 6, 8, 9, 10, 11, 12, 14, 15, 23, 31, 32should be corrected.

END

Thank you for the efforts you put in to improve our manuscript. Your contributions are highly appreciated. Please find our responses below.

---The data has been reviewed and errors have been corrected. Check table 3 page 13. All scientific names have been italicized.

-The authors did not receive any funding for this work. This has been included in the cover letter.

1.The style requirement has been strictly followed.

2.Verbal consent was not specified in the manuscript. Rather, written informed consent was taken. Please see ethical consent and consideration under methodology in our first submission. The same was repeated in the revised manuscript on page 7, line 150

3.Minor occurrence of overlapping with previous publications have been identified, and the statements have been modified. Appropriate references cited. See

Page 14, line 285-287:Page 15 line 308-309: Page 16, line 329-332: page 18, line 369-372, 379-380

4.The authors received no specific funding for this work.

This has been included in the cover letter.

5.The authors have declared that no competing interests exist. This has been included in the cover letter.

6.The data for this study will be made available as supporting information upon acceptance of this manuscript. This has been included in the cover letter.

Thank you for the efforts you put in to improve our manuscript. Your contributions are highly appreciated. Please find our responses below

The discussion has been reviewed. Comparisons of prevalence whose selections were not similar have been removed. See page 14, line 278-283,

This statement “Outdoor transmissions or development of immunity” and “exposure to constant mosquito bites in participants” and their citations have been removed’ Page15, line 295

These comments have been addressed in table 2. See table 2. Page 12, line 251-253

Grammatical errors under methodology were noted and corrected. Page 10, line 215-217

This statement has been modified. See page 10, line 218-220 .

The determination of P.falciparum specie has been clearly explained on page 9, line 184—197

Some of the limitations have been removed. Page 18 line 364-372

The conclusion has been modified. Page 18, line 374-380

1.The missing information has been corrected on page 9,line 184-197

2.This was part of the limitations.

3.Limitations have been modified on page 18 line 364-372

6. Parasite density has been included in Table 2. Page 12, line 254-255

8. The legend has been provided in Table 3. Line 254-255.

The affected sentences in the introduction have been updated including the references. See page 3, line 58-63 and references 2-6 under references.

The description of genotype determination has been modified. See page 9, line 204-205

Table 2 has been modified page 12.

The percentages for Urban and genotype AC have been corrected. Check table 3, page 13

For selection criteria of Ref, check page 10, line 228-229.

The age and sex have been included. Check table 3, on page 13

This statement has been added to the limitation. Check page 18, line 265-267.

All the quoted references have been corrected or replaced. See references.

END

Attachment

Submitted filename: Summary of reviewer.docx

Decision Letter 1

Segun Isaac OYEDEJI

2 May 2023

PONE-D-23-02179R1MALARIA INFECTION AND ITS ASSOCIATION WITH SOCIO-DEMOGRAPHICS, LONG LASTING INSECTICIDE NETS USAGE AND HEMATOLOGICAL PARAMETERS AMONG ADOLESCENT PATIENTS IN RURAL SOUTHWESTERN NIGERIAPLOS ONE

Dear Dr. Ibrahim,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

There are some areas that need the attention of the authors in order to substantially improve the quality of the manuscript, particularly Tables 2 and 3, as well as some references. The authors may choose to request the services of a statistician to help with Tables 2 and 3.

In Table 2 for example, Malaria parasitaemia was classified as Mild parasitaemia, Moderate parasitaemia and Severe parasitaemia in 128 individuals who tested positive for P. falciparum. However, the frequency (N) was erroneously taken as the overall participants enrolled (180) rather than the total number positive for P. falciparum (128). Consequently, the percentages will not add up to 100%.

In Table 3, percentages were generally calculated across rows rather than across columns. Since you are comparing between positives and negatives, the percentages (as well as the statistical analyses) should be calculated/compared across columns rather than across rows. For example, a reader may wish to know the impact of using LLITNs on malaria by comparing the proportion of those using LLITNs among participants who tested positive, with the proportion of those using LLITNs among participants who tested negative.

In addition, under Domicile in Table 3, the Urban percentages (+ve and -ve) do not add up to 100%. Please check and correct.

Please submit your revised manuscript by Jun 16 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Segun Isaac OYEDEJI, Ph.D

Academic Editor

PLOS ONE

Journal Requirements:

1. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments:

INTRODUCTION

Page 3: Lines 57 and 58

Please remove italics from "genus"

Also correct the clause "... of which P. falciparum being the most prevalent." to "... of which P. falciparum is the most prevalent."

Page 3: Lines 57 and 58

Please review the statement "Hematological changes are other factors that may contribute to the transmission of microscopic malaria infection especially in children. Hematological profile may contribute to the clinical presentation of malaria, but not transmission of malaria infection. 

Page 4: Line 96

Please correct the clause "... determined the prevalence malaria infection..." to "... determined the prevalence of malaria infection...". 

DISCUSSION

Page 14: Line 278

Please correct "... higher..." to "...high..." since there was no other group for comparison.

Page 15: Line 297

Plasmodium should be uppercase letter. Please correct "... plasmodium species..." to "... Plasmodium species..." 

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #3: All comments have been addressed

Reviewer #4: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #3: Yes

Reviewer #4: Partly

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #3: Yes

Reviewer #4: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #3: Yes

Reviewer #4: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #3: Yes

Reviewer #4: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #3: All small errors are highlighted in the document provided.

Results

Table 3: The wrong percentages for Domicile Urban (Ref) should be corrected;

References

In the section “References”:

- the ref. 3, 8, 17, 19, 24, 29, should be corrected.

- Line 453-455: font should be corrected.

Reviewer #4: Please, check my comments in the text especially the Discussion section which should be revisited as it does not appropriately address the content of your study

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #3: No

Reviewer #4: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: PONE-D-23-02179_R1_R3.pdf

Attachment

Submitted filename: Review 2023 (2).docx

Attachment

Submitted filename: PONE-D-23-02179_review april 2023.pdf

PLoS One. 2023 Jul 14;18(7):e0287723. doi: 10.1371/journal.pone.0287723.r004

Author response to Decision Letter 1


16 May 2023

SUMMARY OF REVIEWERS’ COMMENTS AND AUTHOR RESPONSE (PONE-D-23-02179R1]

Author’s opening remark: I appreciate the academic editor and other reviewers at improving the quality of our work. Please find my responses to your comments and suggestions below.

Academic editor’s comment Author’s response

--In table 2 for example, Malaria parasitaemia was classified as mild, moderate and severe parasitaemia in 128 individuals who tested positive for P. falciparum. However, the frequency N was erroneously taken as the overall participants enrolled (180) rather than the total number positive for P.falciparum (128). Consequently, the percentages will not add up to 100%.

--In table 3, percentages were generally calculated across rows rather than across columns. Since you are comparing between positives and negatives, the percentages (as well as statistical analyses should be calculated /compared across column rather than across rows. For example, a reader may wish to know the impact of using LLITNs on malaria by comparing the proportion of those using LLITNs among participants who tested positive, with the proportion of those using LLITNs among participants who tested negative.

--In addition, under domicile in table 3, the urban percentages (+ve and –ve) do not add up to 100%. Please, check and correct.

Journal Requirements:

1. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscripts. If you need to cite a retracted article, indicate the articles retracted status in the references list and also include a citation and full reference for the retraction notice.

2. Additional editor comments:

Introduction:

- Page 3: lines 57 and 58. Please remove italics from “genus”

- - Correct the clause” of which P.falciparum being the most prevalent “to –of which P. falciparum is the most prevalent”

- Page 3, line 57 and 58.

- Please review the statement “Hematological changes are other factors that may contribute to the transmission of microscopic malaria infection especially in children. Hematological profile may contribute to the clinical presentation of malaria, but not transmission of malaria infection.

-Page 4, line 96:

Please, correct the clause “determined the prevalence malaria infection ---“to determined the prevalence of malaria infection”

Discussion:

Page 14; LINE 278

Please correct “higher” to high” since there was no other group for comparison.

Page 15, line 297

-Plasmodium should be uppercase letter. Please correct “plasmodium species “to” Plasmodium species”

Reviewer#3:

All small errors are highlighted in the document provided.

Results:

Table 3: The wrong percentages for domicile Urban (ref) should be corrected.

References:

In the section “References”, -the ref. 3,8,17, 24, 29 should be corrected.

-Line 453-455: font should be corrected.

Reviewer #4:

Please check my comments in the text especially the discussion section which should be revisited as it does not appropriately address the content of your study.

END#

Thank you for this observation.

The correction has been effected in table 2, page 12, line 246

-This has been corrected in table 3, page13. All percentages were calculated/compared across columns.

-The correction has been effected in table 3, page 13.

-The reference list has been reviewed. The new references that replaced the previous references were highlighted in pink color under our revised manuscript with track changes. See the reference list

This has been corrected on page 3, Line 53 under the introduction

The correction effected on page 3, line 53-54

The statement has been reviewed. See page 3, line 70-72

-This statement has been modified on page 5, line 95

--This has been corrected on page 14, line 272 , line

----This has been corrected on page 15, line 289

All small errors were corrected and highlighted in the manuscript. See the following pages;

Page 3, line 53,Page 4, line 84, Page 8,line 167, page 10 line 205, page 11 line 232, page 16, line 311, page 16, line 324

This has been corrected, See table 3, page 13

Some of the references (including 3,8,17,24,29) have been corrected while some were replaced with new and current references. These were highlighted in pink color in the reference list in the manuscript.

This has been corrected.

Some paragraphs in the discussion have been re-written and some sentences were replaced. These affected paragraphs and sentences were highlighted in pink color in the manuscript.

These comments have been adequately addressed. Some areas of the discussion as mentioned in the text have been re-written. See page 14, line 269, line 272-275.

Page 16, line 324-344,

Page 17, line 349-355.

END#

Attachment

Submitted filename: SUMMARY OF REVIEWERS.docx

Decision Letter 2

Segun Isaac OYEDEJI

12 Jun 2023

MALARIA INFECTION AND ITS ASSOCIATION WITH SOCIO-DEMOGRAPHICS, LONG LASTING INSECTICIDE NETS USAGE AND HEMATOLOGICAL PARAMETERS AMONG ADOLESCENT PATIENTS IN RURAL SOUTHWESTERN NIGERIA

PONE-D-23-02179R2

Dear Dr. Ibrahim,

Thank you for effecting the necessary corrections as pointed out during the review process. We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Segun Isaac OYEDEJI, Ph.D

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Segun Isaac OYEDEJI

6 Jul 2023

PONE-D-23-02179R2

MALARIA INFECTION AND ITS ASSOCIATION WITH SOCIO-DEMOGRAPHICS, LONG LASTING INSECTICIDE NETS USAGE AND HEMATOLOGICAL PARAMETERS AMONG ADOLESCENT PATIENTS IN RURAL SOUTHWESTERN NIGERIA.

Dear Dr. Ibrahim:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Professor Segun Isaac OYEDEJI

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 File

    (DOCX)

    S1 Data

    (XLSX)

    Attachment

    Submitted filename: Review 2023.docx

    Attachment

    Submitted filename: Summary of reviewer.docx

    Attachment

    Submitted filename: PONE-D-23-02179_R1_R3.pdf

    Attachment

    Submitted filename: Review 2023 (2).docx

    Attachment

    Submitted filename: PONE-D-23-02179_review april 2023.pdf

    Attachment

    Submitted filename: SUMMARY OF REVIEWERS.docx

    Data Availability Statement

    All relevant data are within the paper and its Supporting Information files.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES